CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Abroad (travel likely)Recruiting

Conditions

Generalized Pustular Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CorEvitas, LLC, Waltham, Massachusetts, United States
Contact: Study coordinator (Cathy Cheney) · corevitasregistrytrials@corevitas.com

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis

Generalized Pustular Psoriasis

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China

Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

Generalized Pustular Psoriasis (GPP)

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Shanghai, China

Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis

Generalized Pustular Psoriasis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China · Beijing, China